LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-κB pathway.

Zhang HJ, Wei QF, Wang SJ, Zhang HJ, Zhang XY, Geng Q, Cui YH, Wang XH

Open source

DOI
10.1016/j.intimp.2017.06.021
Published
2017 Sep
Container
International immunopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2017.06.021,
  title = {LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-κB pathway.},
  author = {Zhang HJ and Wei QF and Wang SJ and Zhang HJ and Zhang XY and Geng Q and Cui YH and Wang XH},
  year = {2017},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2017.06.021},
  url = {https://doi.org/10.1016/j.intimp.2017.06.021}
}

RIS

TY  - JOUR
TI  - LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-κB pathway.
AU  - Zhang HJ
AU  - Wei QF
AU  - Wang SJ
AU  - Zhang HJ
AU  - Zhang XY
AU  - Geng Q
AU  - Cui YH
AU  - Wang XH
PY  - 2017
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2017.06.021
UR  - https://doi.org/10.1016/j.intimp.2017.06.021
ER  - 

APA

HJ, Z., QF, W., SJ, W., HJ, Z., XY, Z., Q, G., YH, C., & XH, W. (2017). LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-κB pathway.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2017.06.021

Source records